Sellami D, Abid S, Bouaouaja G, Ben Amor S, Kammoun B, Masmoudi M, Dabbeche K, Boumoud H, Ben Zina Z, Feki J
Department of Ophthalmology, CHU Habib Bourguiba, 3029 Sfax, Tunisia.
Transplant Proc. 2007 Oct;39(8):2609-11. doi: 10.1016/j.transproceed.2007.08.020.
The aim of this study was to evaluate the frequency and main risk factors for corneal graft rejection.
This retrospective study included 285 eyes in 256 patients who underwent a penetrating keratoplasty (KPT) from January 1995 to December 2004. The minimum follow-up was 12 months to evaluate graft evolution. Except for complications, the follow-up was weekly, then monthly for 6 months, and ultimately quarterly during the first year. Thereafter the follow-up was performed semi-annually. Patients were informed about the functional signs for which they have to urgently consult.
Immunologic rejection of the corneal graft occurred in 128 KPT in 112 patients (rejection frequency = 41%). The identified main risk factors were new vascularization of the recipient cornea over 2 or more quadrants, corneal opacity due to an infectious origin, posttraumatic corneal opacity or congenital glaucoma, graft diameter >8 mm, and therapeutic KPT.
Rejection of the corneal graft is the primary cause of KPT failure. One out of 2 graft failures was due to rejection. Two criteria are unanimously recognized as risk factors for rejection: neovascularization of recipient cornea and antecedents of corneal rejection. The rejection must be treated early to not endanger graft success, which imposes a close follow-up for grafted patients.
本研究旨在评估角膜移植排斥反应的发生率及主要危险因素。
这项回顾性研究纳入了1995年1月至2004年12月期间接受穿透性角膜移植术(KPT)的256例患者的285只眼。最短随访时间为12个月,以评估移植片的进展情况。除并发症外,随访最初为每周一次,然后6个月内每月一次,在第一年最终为每季度一次。此后每半年进行一次随访。告知患者若出现需紧急就诊的功能体征。
112例患者的128只穿透性角膜移植眼中发生了角膜移植免疫排斥反应(排斥反应发生率 = 41%)。确定的主要危险因素为受体角膜2个或更多象限出现新的血管化、感染性病因导致的角膜混浊、创伤后角膜混浊或先天性青光眼、移植片直径>8 mm以及治疗性穿透性角膜移植术。
角膜移植排斥反应是穿透性角膜移植术失败的主要原因。每2例移植失败中有1例是由排斥反应所致。有两个标准被一致认为是排斥反应的危险因素:受体角膜新生血管化和角膜排斥反应史。必须尽早治疗排斥反应以免危及移植成功,这就要求对接受移植的患者进行密切随访。